Original Research

Published on 12 Sep 2022

Detection of BRCA1/2 pathogenic variants in patients with breast and/or ovarian cancer and their families. Analysis of 3,458 cases from Lower Silesia (Poland) according to the diagnostic algorithm of the National Cancer Control Programme

in Cancer Genetics and Oncogenomics

Anna Doraczynska-Kowalik
Dagmara Michalowska
Rafal Matkowski
Ewelina Czykalko
Dorota Blomka
Mariola Semeniuk
Mariola Abrahamowska
Gabriela Janus-Szymanska
Paulina Mlynarczykowska
Bartlomiej Szynglarewicz

Frontiers in Genetics

doi 10.3389/fgene.2022.941375

3,944 views
1 citation

Original Research

Published on 12 Sep 2022

A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma

in Cancer Genetics and Oncogenomics

Xin-Yi Liang
Yue Zhang
Ya-Nan He
Xue-Yi Liu
Zhi-Hao Ding
Xiao-Dong Zhang
Ming-You Dong
Run-Lei Du

Frontiers in Genetics

doi 10.3389/fgene.2022.888601

3,676 views
2 citations

Original Research

Published on 12 Sep 2022

Anti-proliferative and pro-apoptotic effects of curcumin on skin cutaneous melanoma: Bioinformatics analysis and in vitro experimental studies

in Cancer Genetics and Oncogenomics

Long Li
Shuwen Lu
Chao Ma

Frontiers in Genetics

doi 10.3389/fgene.2022.983943

2,364 views
5 citations

Original Research

Published on 12 Sep 2022

Integration of single-cell and bulk RNA-seq to establish a predictive signature based on the differentiation trajectory of M2 macrophages in lung adenocarcinoma

in Cancer Genetics and Oncogenomics

Zhike Chen
Jian Yang
Yu Li
Weibiao Zeng
Yiling Bai
Cheng Ding
Chun Xu
Chang Li
Jun Chen
Sheng Ju

Frontiers in Genetics

doi 10.3389/fgene.2022.1010440

5,318 views
7 citations

Original Research

Published on 09 Sep 2022

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy

in Cancer Genetics and Oncogenomics

Zhengjun Lin
Yanlin Wu
XunGang Xiao
Xianghong Zhang
Jia Wan
Tao Zheng
Hongxuan Chen
Tang Liu
Xianzhe Tang

Frontiers in Genetics

doi 10.3389/fgene.2022.938510

5,316 views
1 citation

Original Research

Published on 09 Sep 2022

Comparison of effectiveness and safety of camrelizumab between HBV-related and non-B, non-C hepatocellular carcinoma: A retrospective study in China

in Cancer Genetics and Oncogenomics

Haonan Liu
Xiaobing Qin
Zhiyuan Xu
Meng Wu
Tong Lu
Shuang Zhou
Nan Yao
Suya Liu
Yong Shao
Zhengxiang Han

Frontiers in Genetics

doi 10.3389/fgene.2022.1000448

2,054 views
6 citations

Original Research

Published on 09 Sep 2022

MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma

in Cancer Genetics and Oncogenomics

Lei Zhou
Guojie Chen
Tao Liu
Xinyuan Liu
Chengxiao Yang
Jianxin Jiang

Frontiers in Genetics

doi 10.3389/fgene.2022.965805

3,683 views
1 citation

Review

Published on 09 Sep 2022

Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system

in Cancer Genetics and Oncogenomics

Nirashaa T. Bound
Cassandra J. Vandenberg
Apriliana E. R. Kartikasari
Magdalena Plebanski
Clare L. Scott

Frontiers in Genetics

doi 10.3389/fgene.2022.886170

7,507 views
8 citations

Original Research

Published on 09 Sep 2022

Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma

in Cancer Genetics and Oncogenomics

Wei Yu
Hongqi Huo
Zhixin You
Rong Lu
Tianci Yao
Jing Huang

Frontiers in Genetics

doi 10.3389/fgene.2022.982888

3,768 views
4 citations

Original Research

Published on 09 Sep 2022

COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer

in Cancer Genetics and Oncogenomics

Qi Luo
Jinsui Li
Xiaohan Su
Qiao Tan
Fangfang Zhou
Shaoli Xie

Frontiers in Genetics

doi 10.3389/fgene.2022.935860

5,055 views
9 citations

Original Research

Published on 09 Sep 2022

FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC

in Cancer Genetics and Oncogenomics

Dong-Mei Hu
Wen-Di Zhang
Zhuang-E Shi
Meng-Yu Zhang
Rui Li
Qing-Xiang Wang
Xiu-Li Ji
Yi-Qing Qu

Frontiers in Genetics

doi 10.3389/fgene.2022.937069

3,016 views
1 citation

Original Research

Published on 08 Sep 2022

Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma

in Cancer Genetics and Oncogenomics

You Zuo
Shuai Fu
Zhongwei Zhao
Zeyan Li
Yijian Wu
Tienan Qi
Jianguo Zheng
Qinglong Du
Zhonghua Xu
Nengwang Yu

Frontiers in Genetics

doi 10.3389/fgene.2022.985641

3,290 views
3 citations

Original Research

Published on 08 Sep 2022

High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer

in Cancer Genetics and Oncogenomics

Rui Chen
Xinyang Wang
Jingyue Fu
Mengdi Liang
Tiansong Xia

Frontiers in Genetics

doi 10.3389/fgene.2022.956869

3,893 views
11 citations

Review

Published on 08 Sep 2022

Microfluidic devices: The application in TME modeling and the potential in immunotherapy optimization

in Cancer Genetics and Oncogenomics

Yuting Li
Honghong Fan
Junli Ding
Junying Xu
Chaoying Liu
Huiyu Wang

Frontiers in Genetics

doi 10.3389/fgene.2022.969723

4,194 views
10 citations

Original Research

Published on 08 Sep 2022

Complement system-related genes in stomach adenocarcinoma: Prognostic signature, immune landscape, and drug resistance

in Cancer Genetics and Oncogenomics

Xiaoxia Tong
Xiaohu Yang
Xiaojuan Tong
Dong Zhai
Yonglei Liu

Frontiers in Genetics

doi 10.3389/fgene.2022.903421

3,260 views
6 citations

Original Research

Published on 08 Sep 2022

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors

in Cancer Genetics and Oncogenomics

Huihui Zhao
Rongrong Xie
Chenxi Zhang
Guojun Lu
Hui Kong

Frontiers in Genetics

doi 10.3389/fgene.2022.989460

4,075 views
6 citations

Navigation group

Articles

Detection of BRCA1/2 pathogenic variants in patients with breast and/or ovarian cancer and their families. Analysis of 3,458 cases from Lower Silesia (Poland) according to the diagnostic algorithm of the National Cancer Control Programme

A cancer stem cell associated gene signature for predicting overall survival of hepatocellular carcinoma

Anti-proliferative and pro-apoptotic effects of curcumin on skin cutaneous melanoma: Bioinformatics analysis and in vitro experimental studies

Integration of single-cell and bulk RNA-seq to establish a predictive signature based on the differentiation trajectory of M2 macrophages in lung adenocarcinoma

Pan-cancer analysis of CREB3L1 as biomarker in the prediction of prognosis and immunotherapeutic efficacy

Comparison of effectiveness and safety of camrelizumab between HBV-related and non-B, non-C hepatocellular carcinoma: A retrospective study in China

MJDs family members: Potential prognostic targets and immune-associated biomarkers in hepatocellular carcinoma

Improving PARP inhibitor efficacy in high-grade serous ovarian carcinoma: A focus on the immune system

Identification of cuproptosis-associated IncRNAs signature and establishment of a novel nomogram for prognosis of stomach adenocarcinoma

COL11A1 serves as a biomarker for poor prognosis and correlates with immune infiltration in breast cancer

FOXP family DNA methylation correlates with immune infiltration and prognostic value in NSCLC

Sarcomatoid-associated gene risk index for clear cell renal cell carcinoma

High FLT3 expression indicates favorable prognosis and correlates with clinicopathological parameters and immune infiltration in breast cancer

Microfluidic devices: The application in TME modeling and the potential in immunotherapy optimization

Complement system-related genes in stomach adenocarcinoma: Prognostic signature, immune landscape, and drug resistance

Pan-cancer analysis of prognostic and immunological role of DTYMK in human tumors